Home/Pipeline/Magnetic Delivery Platform

Magnetic Delivery Platform

Inner/Middle Ear Disorders (e.g., hearing preservation, otitis media)

Pre-clinicalActive

Key Facts

Indication
Inner/Middle Ear Disorders (e.g., hearing preservation, otitis media)
Phase
Pre-clinical
Status
Active
Company

About Otomagnetics

Otomagnetics is pioneering a novel, non-invasive drug delivery platform that uses magnetic forces to transport therapeutic agents across biological barriers. Its initial targets are the inner and middle ear, where current delivery methods are highly invasive or ineffective, addressing significant unmet needs in otology. The technology also holds promise for ocular and dermatological applications, potentially revolutionizing local drug administration. Founded in 2015, the company is in the pre-clinical development stage, building a platform with broad therapeutic potential.

View full company profile

About Otomagnetics

Otomagnetics is pioneering a novel, non-invasive drug delivery platform that uses magnetic forces to transport therapeutic agents across biological barriers. Its initial targets are the inner and middle ear, where current delivery methods are highly invasive or ineffective, addressing significant unmet needs in otology. The technology also holds promise for ocular and dermatological applications, potentially revolutionizing local drug administration. Founded in 2015, the company is in the pre-clinical development stage, building a platform with broad therapeutic potential.

View full company profile

About Otomagnetics

Otomagnetics is pioneering a novel, non-invasive drug delivery platform that uses magnetic forces to transport therapeutic agents across biological barriers. Its initial targets are the inner and middle ear, where current delivery methods are highly invasive or ineffective, addressing significant unmet needs in otology. The technology also holds promise for ocular and dermatological applications, potentially revolutionizing local drug administration. Founded in 2015, the company is in the pre-clinical development stage, building a platform with broad therapeutic potential.

View full company profile